Read Time:1 Minute, 4 Second
Sputnik Light is developed by Russia’s Gamaleya Center, built on a human adenovirus vector platform. In October last year, the government had approved the export of Sputnik Light, manufactured in India by Hetero Biopharma Limited.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
More Stories
Long Covid Symptoms Affect 1 In 8, Suggests Lancet Study
With more than half a billion coronavirus cases recorded worldwide since the start of the pandemic, there has been rising...
Covid Virus May Survive For 30 Days On Refrigerated, Frozen Meat: Study
The research, recently published in the journal Applied and Environmental Microbiology, was conducted using chicken, beef, pork, and salmon, and...
China’s New Covid Outbreaks Put Millions Under Lockdown – Again
Chinese health authorities reported over 300 Covid infections today, with clusters found in the historic northern city of Xi'an as...
China Resumes International Flights After 2-Year Covid Ban
China is further streamlining procedures for those arriving into the country after reducing the quarantine time to 7 days in...
North Korea Blames “Alien Things” Near South Korea Border For Covid
According to the state media KCNA, an 18-year-old soldier and a five-year-old kindergartener who contacted the unidentified materials in a...
“Misleading”: China Leader’s Quote On 5 Years Of ‘Zero-Covid’ Policy Removed
The misleading quote was made by Beijing's city party chief, Cai Qi, in Beijing Daily, the official Communist Party newspaper...
The subject expert panel on vaccines has recommended the drug regulator to grant emergency use authorisation (EUA) to Russia’s Sputnik Light single-dose vaccine, sources said on Friday.
Sputnik Light is developed by Russia’s Gamaleya Center, built on a human adenovirus vector platform. In October last year, the government had approved the export of Sputnik Light, manufactured in India by Hetero Biopharma Limited.
The Sputnik is the same as component-1 of the Russian Sputnik V vaccine that has been used in India’s vaccination drive. India has administered close to 12 lakh doses of Sputnik V during the adult vaccination drive.
The company had earlier said that the single-shot vaccine has demonstrated 70 per cent efficacy against infection by the Delta variant.
“A preliminary study of the Gamaleya Center has found Sputnik Light significantly increases virus neutralizing activity against Omicron based on sera 2-3 months after revaccination with 100% of individuals revaccinated with Sputnik Light as a booster having developed neutralizing antibodies against this variant,” the Russian Direct Investment Fund had said earlier.